Cite
HARVARD Citation
Pope, J. et al. (2015). Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity. Arthritis research & therapy. 17 (1), pp. 1-10. [Online].